Terms: = Breast cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
538 results:
1. pDNA-tachyplesin treatment stimulates the immune system and increases the probability of apoptosis in MC4-L2 tumor cells.
Mahmoudi-Filabadi F; Doosti A
Amino Acids; 2024 May; 56(1):34. PubMed ID: 38691208
[TBL] [Abstract] [Full Text] [Related]
2. An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma.
Wang X; Ren T; Liao C; Xie Y; Cao J
BMC Genomics; 2024 Feb; 25(1):205. PubMed ID: 38395786
[TBL] [Abstract] [Full Text] [Related]
3. Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International breast cancer Study Group (IBCSG) Trial 22-00.
Rusakiewicz S; Tyekucheva S; Tissot-Renaud S; Chaba K; Imbimbo M; Benedetti F; Kammler R; Hornfeld J; Munzone E; Gianni L; Thurlimann B; Láng I; Pruneri G; Gray KP; Regan MR; Loi S; Colleoni M; Viale G; Kandalaft L; Coukos G; Curigliano G
Eur J Cancer; 2024 Mar; 200():113535. PubMed ID: 38309015
[TBL] [Abstract] [Full Text] [Related]
4. The relationship between high ratios of CD4/foxp3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study.
Tenggara JB; Rachman A; Prihartono J; Rachmadi L; Panigoro SS; Heriyanto DS; Sutandyo N; Nasution IR; Rahadiati FB; Steven R; Betsy R; Juanputra S; Sudoyo AW
BMC Res Notes; 2024 Feb; 17(1):44. PubMed ID: 38308298
[TBL] [Abstract] [Full Text] [Related]
5. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
[TBL] [Abstract] [Full Text] [Related]
7. Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers.
Lashen A; Al-Kawaz A; Jeyapalan JN; Alqahtani S; Shoqafi A; Algethami M; Toss M; Green AR; Mongan NP; Sharma S; Akbari MR; Rakha EA; Madhusudan S
Neoplasia; 2024 Jan; 47():100957. PubMed ID: 38134458
[TBL] [Abstract] [Full Text] [Related]
8. Components of the tumor immune microenvironment based on m-IHC correlate with prognosis and subtype of triple-negative breast cancer.
Lin L; Li H; Wang X; Wang Z; Su G; Zhou J; Sun S; Ma X; Chen Y; You C; Gu Y
Cancer Med; 2023 Dec; 12(24):21639-21650. PubMed ID: 38059408
[TBL] [Abstract] [Full Text] [Related]
9. Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation.
Liu P; Deng X; Zhou H; Xie J; Kong Y; Zou Y; Yang A; Li X
Front Immunol; 2023; 14():1297180. PubMed ID: 38022619
[TBL] [Abstract] [Full Text] [Related]
10. Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016).
Pellegrino B; Tommasi C; Serra O; Gori S; Cretella E; Ambroggi M; Frassoldati A; Bisagni G; Casarini C; Bria E; Carbognin L; Fiorio E; Mura A; Zamagni C; Gianni L; Zambelli A; Montemurro F; Tognetto M; Todeschini R; Missale G; Campanini N; Silini EM; Maglietta G; Musolino A
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38016718
[TBL] [Abstract] [Full Text] [Related]
11. Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy.
Jalilian E; Abolhasani-Zadeh F; Afgar A; Samoudi A; Zeinalynezhad H; Langroudi L
Sci Rep; 2023 Nov; 13(1):20770. PubMed ID: 38008819
[TBL] [Abstract] [Full Text] [Related]
12. Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.
Gandhi S; Opyrchal M; Grimm MJ; Slomba RT; Kokolus KM; Witkiewicz A; Attwood K; Groman A; Williams L; Tarquini ML; Wallace PK; Soh KT; Minderman H; Maguire O; O'Connor TL; Early AP; Levine EG; Kalinski P
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37963636
[TBL] [Abstract] [Full Text] [Related]
13. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
Hamed A; Ghareeb D; Mohamed TM; Hamed M; Nofal MS; Gaber M
BMC Complement Med Ther; 2023 Oct; 23(1):384. PubMed ID: 37891562
[TBL] [Abstract] [Full Text] [Related]
14. Dormant tumors circumvent tumor-specific adaptive immunity by establishing a Treg-dominated niche via DKK3.
Trotter TN; Dagotto CE; Serra D; Wang T; Yang X; Acharya CR; Wei J; Lei G; Lyerly HK; Hartman ZC
JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37847565
[TBL] [Abstract] [Full Text] [Related]
15. Dynamic Responses of Circulating T Cells After Stereotactic Body Radiation Therapy for Bone Metastasis in Patients With breast cancer.
Jeon SH; Jang BS; Kim DY; Kim JH; Shin EC; Kim IA
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):790-800. PubMed ID: 37802227
[TBL] [Abstract] [Full Text] [Related]
16. Targeting foxp3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental breast cancer.
Nicola Candia AJ; Garcia Fallit M; Peña Agudelo JA; Pérez Küper M; Gonzalez N; Moreno Ayala MA; De Simone E; Giampaoli C; Casares N; Seilicovich A; Lasarte JJ; Zanetti FA; Candolfi M
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766222
[TBL] [Abstract] [Full Text] [Related]
17. Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer.
Gaui MFD; Amendola LC; Quintella DC; Canedo N; Bonomo A
Rev Assoc Med Bras (1992); 2023; 69(9):e20230276. PubMed ID: 37729362
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
Matsuda N; Yamamoto H; Habu T; Iwata K; Matsubara K; Tanaka S; Hashimoto K; Shien K; Suzawa K; Miyoshi K; Toji T; Okazaki M; Sugimoto S; Takahashi K; Toyooka S
Ann Surg Oncol; 2023 Dec; 30(13):8727-8734. PubMed ID: 37658268
[TBL] [Abstract] [Full Text] [Related]
19. pH-Responsive Zinc Ion Regulating Immunomodulatory Nanoparticles for Effective cancer Immunotherapy.
Lim B; Kim KS; Na K
Biomacromolecules; 2023 Sep; 24(9):4263-4273. PubMed ID: 37616157
[TBL] [Abstract] [Full Text] [Related]
20. Periprosthetic effusions surrounding breast expander: a flow cytometric, immunohistochemical and molecular characterization.
Sala L; Ciniselli CM; Bozzi F; Summo V; Bonini C; Brich S; Bertolotti A; Trupia DV; Volpi CC; Pizzamiglio S; Paolini B; Aiello A; Apolone G; Verderio P; Cortinovis U
Tumori; 2024 Feb; 110(1):49-59. PubMed ID: 37574933
[TBL] [Abstract] [Full Text] [Related]
[Next]
